EFC (I)'s (NSE:EFCIL, BOM:512008) consolidated attributable profit rose to 694.0 million Indian rupees in the fiscal fourth quarter ended March 31, from 438.8 million rupees a year ago.
Earnings per share came in at 5.06 rupees from 3.20 rupees a year earlier, the coworking and managed office operator said in a filing to the Indian stock exchanges on Thursday.
Revenue from operations in fiscal Q4 increased to 2.92 billion rupees from 2.11 billion rupees a year ago.
1414 Degrees (ASX:14D) began the scale-up phase of its SiNTL silicon nanoparticle anode program and initiated full-stack battery development with contract manufacturers, acquiring scale-up equipment to produce manufacturer-relevant quantities of its silicon anode material at research partner George Washington University in Washington DC, according to a Friday Australian bourse filing.The company said the scale-up enables it to progress industry discussions into formal third-party evaluations and original equipment manufacturer qualification processes, with several drone and related industry participants engaged and inbound interest received from companies seeking to trial SiNTL materials.The company said silicon offers a theoretical capacity of about 3,600 milliampere-hours per gram compared to about 372 milliampere-hours per gram for graphite anodes, with SiNTL aimed at addressing battery capacity as a key constraint across many unmanned aerial vehicle systems, the filing added.The company's shares surged 16% to their highest since November 2021 in recent Friday trade.
Intelligent Monitoring Group (ASX:IMB) completed the acquisition of BlueSky Holdco from Johnson Control Luxembourg European Finance, a Johnson Controls International subsidiary, according to a Friday filing with the Australian bourse.The transaction includes the purchase of fire protection service and security providers Tyco NZ and Red Wolf Security for NZ$45 million, the filing said.The company's shares were up nearly 1% in recent Friday trade.
Sino Medical Sciences Technology (SHA:688108) applied to list H shares on the Hong Kong Stock Exchange, according to a Thursday filing with the Shanghai bourse.The listing remains subject to approvals from Chinese and Hong Kong regulators, including the China Securities Regulatory Commission and the Hong Kong Securities and Futures Commission.Shares of the medical device manufacturer rose 2% in recent trade.